Zonula Incorporated

Targeted therapies for cadherin-dependent diseases

  • Stage Product In Development
  • Industry Biotechnology
  • Location Montreal, QC, Canada
  • Currency CAD
  • Founded October 2018
  • Employees 1
  • Incorporation Type Other
  • Website zonulainc.com

Company Summary

We are a biotech startup with novel drugs that change how cells stick together. Zonula will develop these to provide new therapies for several diseases including arthritis and cancer.

Team

  • Axel Thomson
    CEO

    Dr Axel Thomson is a academic cancer and developmental biologist and biotech consultant. He has led the development of Zonula applications in tumour biology.

  • Orest Blaschuk
    Founder and President

    Professor Blaschuk has thirty years of experience in Cadherin research at McGill University, and has successfully translated his work by founding two companies.

  • Arkadii Vaisburg
    Vice President Chemistry

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free